James E Dentzer
President & CEO, Director at Curis Inc (CRIS)
James E Dentzer has filed 22 insider reports with the SEC since January 2021, as director at Imunon, Inc. (IMNN) and president & CEO and director at Curis Inc (CRIS). James E Dentzer made no open-market purchases or sales in the last 12 months. The latest filing, on November 11, 2026, reports grant or award at Imunon, Inc. (IMNN).
- Filings
- 22
- Companies
- 2
- Bought on market
- None
- Sold on market
- $74.9K
Companies where James E Dentzer is an insider
| Company | Role | Shares held | Bought | Sold | Avg buy | Price now | Last filing |
|---|---|---|---|---|---|---|---|
| Directorsince September 2022 | 34,197 | $0.6122 | Nov 11, 2026 | ||||
| President & CEO, Director | 148,730 | $74.9K | $0.5418 | Jul 9, 2026 |
Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.
Every filing
- Nov 6, 2026IMNNDirector Dentzer James E was granted 13,166 shares, increasing direct ownership by 63% to 34,197 unitsForm 4Grant or award
- Jul 31, 2026IMNNDirector Dentzer James E was granted 6,934 shares, increasing direct ownership by 46% to 21,897 unitsForm 4Grant or award
- Jul 7, 2026CRISSEC Form 4 filed by President & CEO Dentzer James EForm 4Grant or award
- May 22, 2026IMNNDirector Dentzer James E was granted 11,148 shares, increasing direct ownership by 292% to 14,963 unitsForm 4Grant or award
- Mar 20, 2026CRISSEC Form 4 filed by Dentzer James EForm 4Conversion of a derivative
- Mar 17, 2026CRISSEC Form 4 filed by Dentzer James EForm 4Grant or award
- Jan 2, 2026IMNNSEC Form 4 filed by Director Dentzer James EForm 4Grant or award
- Aug 4, 2025IMNNDirector Dentzer James E was granted 3,318 sharesForm 4Grant or award
- May 20, 2025CRISSEC Form 4 filed by President & CEO Dentzer James EForm 4Grant or award
- Mar 14, 2025IMNNSEC Form 4 filed by Director Dentzer James EForm 4Grant or award
- Jan 28, 2025CRISSEC Form 4 filed by President & CEO Dentzer James EForm 4Grant or award
- Sep 6, 2024IMNNSEC Form 4 filed by Director Dentzer James EForm 4Grant or award
- Jun 12, 2024IMNNSEC Form 4 filed by Director Dentzer James EForm 4Grant or award
- May 21, 2024CRISSEC Form 4 filed by Dentzer James EForm 4Grant or award
- Mar 15, 2024IMNNSEC Form 4 filed by Dentzer James EForm 4Grant or award
- Mar 17, 2023IMNNSEC Form 4 filed by Dentzer James EForm 4Grant or award
- Jan 20, 2023CRISSEC Form 4 filed by Dentzer James EForm 4Grant or award
- Sep 30, 2022IMNNSEC Form 4 filed by Dentzer James EForm 4Grant or award
- Sep 29, 2022IMNNSEC Form 3: New insider Dentzer James E claimed no ownership of stock in the companyForm 3New insider
- Jan 31, 2022-$17.1KCRISSEC Form 4: Dentzer James E sold $17,150 worth of shares (5,500 units at $3.12) as part of a pre-agreed trading plan, decreasing direct ownership by 8% to 64,877 units to satisfy tax liabilityForm 4Grant or awardOpen-market sale10b5-1 plan
- Jan 28, 2021CRISSEC Form 4 filed by E James DentzerForm 4Grant or award
- Jan 26, 2021-$57.8KCRISSEC Form 4: E James Dentzer sold $57,931 worth of Common Stock (5,377 units at $10.77), decreasing ownership by 7% to 67,268 unitsForm 4Open-market sale10b5-1 plan
Compare James E Dentzer with
- James E Dentzer vs Donald P Braun1 shared
- James E Dentzer vs Christine A Pellizzari1 shared
- James E Dentzer vs Frederick J. Fritz1 shared
- James E Dentzer vs Douglas Vincent Faller1 shared
- James E Dentzer vs Stacy Lindborg1 shared
- James E Dentzer vs Michael H Tardugno1 shared
Other insiders at the same companies
- Donald P BraunIMNN
- Christine A PellizzariIMNN
- Frederick J. FritzIMNN
- Douglas Vincent FallerIMNN
- Stacy LindborgIMNN
- Michael H TardugnoIMNN
- Susan EylwardIMNN
- Marc RubinCRIS
- Kenneth I KaitinCRIS
- John HohnekerCRIS
- Martyn D GreenacreCRIS
- Anne Elizabeth BorgmanCRIS
- Diantha DuvallCRIS
- Jonathan B. ZungCRIS
- Joshua BlacherIMNN
- Ahmed MD HamdyCRIS
Questions about James E Dentzer
- What is James E Dentzer's role at Curis Inc?
- James E Dentzer reports to the SEC as president & CEO and director at Curis Inc (CRIS), according to the latest filing on July 9, 2026. James E Dentzer has also filed as director at Imunon, Inc. (IMNN).
- How many shares does James E Dentzer own?
- After the latest filing that states it, James E Dentzer directly owned 34,197 shares of Imunon, Inc. (IMNN) and 148,730 shares of Curis Inc (CRIS). Shares held through trusts, funds or family members are reported separately and are not counted here.
- Has James E Dentzer bought or sold stock recently?
- The most recent open-market sale was on January 31, 2022: sold 5,500 shares of Curis Inc (CRIS) for $17.1K at an average of $3.12.
- How do I get alerts when James E Dentzer files?
- Follow James E Dentzer on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale. James E Dentzer filed 1 time in the last 90 days.
From SEC Forms 3, 4, 5 and 144 filed by James E Dentzer (SEC CIK 0001400977). Totals count each trade once, skipping amendments whose original is on file, from Jan 26, 2021 on. View on SEC EDGAR